Inovio Pharmaceuticals, Inc. · NASDAQ:INO

Sumner Michael John exercised options for 4,292 Inovio Pharmaceuticals, Inc. shares (Form 4)

Traded Mar 31, 2026 · Filed Apr 1, 2026

On Mar 31, 2026, Sumner Michael John (Chief Medical Officer) exercised options for 4,292 Inovio Pharmaceuticals, Inc. shares, leaving 33,576 shares. Filed Apr 1, 2026 (Form 4).

Options exercised
4,292 shares
Holding after
33,576 shares
Trading plan
No
Role
Chief Medical Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Mar 31, 2026Common StockOption exercise4,29234,799Direct
Mar 31, 2026Common StockShares withheld for tax1,223US$1.7433,576Direct

Source

View original at SEC

Related